Compare Two Stocks
Valuation, growth, earnings reaction and guidance credibility, side by sideTMOThermo Fisher Scientific
FinDog View：Neutral
| Metric | PFE | TMO |
|---|
| Close | 30.52 | 697.00 |
| Market Cap | $174B | $258B |
| 1M | +7.01% | +3.25% |
| P/E (TTM) | 40.0 | 36.4 |
| Forward P/E | 9.6 | 24.6 |
| P/E 5-Yr Percentile | 90 | 78 |
| P/S | 2.7 | 5.4 |
| P/B | 2.0 | 4.7 |
| Dividend Yield | 5.38% | 0.29% |
| Latest Quarter Revenue | $15.0B | $12.1B |
| Revenue YoY | +2.6% | +9.1% |
| Gross Margin | 72.8% | — |
| Latest Quarter EPS | -0.04 | 4.64 |
| Avg Post-Earnings Move | ±2.2% | ±1.2% |
| EPS Beat Rate | — | — |
| Guidance Hit Rate | — | — |
| Shareholder Yield | — | 1.82% |
| 90-Day Net Insider Buying | +$2.9M | −$40.3M |
PFE · Revenue, Last 8 Quarters ($B)
TMO · Revenue, Last 8 Quarters ($B)
